Maze Therapeutics, Inc. Common Stock (MAZE) — Cash Flow Reinvestment Rate
Maze Therapeutics, Inc. Common Stock (MAZE) has a Cash Flow Reinvestment Rate of 0.00x as of June 2024, reinvesting $320.00K (capex $160.00K plus investments $-160.00K) from operating cash flow of $145.05 Million. Check Maze Therapeutics, Inc. Common Stock earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Maze Therapeutics, Inc. Common Stock Cash Flow Reinvestment Rate (2024–2024)
Historical reinvestment intensity for Maze Therapeutics, Inc. Common Stock across 1 annual periods. Explore MAZE long-term investments to assets to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Maze Therapeutics, Inc. Common Stock (2024–2024)
Year-by-year capital reinvestment analysis for Maze Therapeutics, Inc. Common Stock. For live market cap and broader valuation context, see how much is Maze Therapeutics, Inc. Common Stock worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.03x | $2.29 Million | $75.95 Million | $1.15 Million | — |